Bethany L. Sensenig — SUPERNUS PHARMACEUTICALS Director Compensation (2025)

What they were paid

SUPERNUS PHARMACEUTICALS Director Compensation Table · all 2 fiscal years held

In US dollars, as SUPERNUS PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal year	Cash fees	Stock awards	Option awards	Other	Total
FY2025	$62,500	$150,002	$150,011	$0	$362,513
FY2024	$62,500	$150,010	$142,678	—	$355,188

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SUPERNUS PHARMACEUTICALS, INC. DEF 14A filed April 30, 2026, accession 0001104659-26-053111, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

SUPERNUS PHARMACEUTICALS pays directors a $50,000 cash retainer and $300,000 in RSUs and Options (50/50 split).

Committees

FY2025 · as the proxy prints them

Audit

The rest of the SUPERNUS PHARMACEUTICALS board

FY2025 · as the company reported each

Director	Role	FY2025 total
Carrolee Barlow	Independent Director	$376,013
Charles W. Newhall, III	Chair of the Board	$417,013
Frederick M. Hudson	Independent Director	$385,013
Georges Gemayel	Independent Director	$398,513
Jack A. Khattar	Director	$0

The full SUPERNUS PHARMACEUTICALS compensation record

free company brief

This page is one director within SUPERNUS PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat